**Core Concept**
Mycobacterium leprae is the causative agent of leprosy, a chronic bacterial infection affecting the skin, nerves, and mucous membranes. The treatment of leprosy requires a combination of antimicrobial agents to effectively eradicate the bacteria.

**Why the Correct Answer is Right**
Rifampicin is a potent bactericidal agent that acts by inhibiting RNA synthesis in bacteria. It is particularly effective against M. leprae, with a rapid onset of action and a long duration of killing. Rifampicin's ability to induce the expression of the ribosomal RNA operon leads to the degradation of the bacterial RNA, ultimately resulting in cell death. This mechanism makes rifampicin the fastest microbiocidal agent against M. leprae.

**Why Each Wrong Option is Incorrect**
**Option A:** Clofazimine is an antimicrobial agent used in the treatment of leprosy, but it has a slower onset of action and is less potent against M. leprae compared to rifampicin.
**Option B:** Dapsone is another antimicrobial agent used in leprosy treatment, but it has a slower bactericidal effect and is often used in combination with other agents to achieve optimal results.
**Option C:** Isoniazid is primarily used in the treatment of tuberculosis and is not as effective against M. leprae as rifampicin.

**Clinical Pearl / High-Yield Fact**
Rifampicin is a well-known enzyme inducer, which can lead to decreased plasma concentrations of other medications, including anticoagulants and cyclosporine. This interaction should be considered when prescribing rifampicin to patients on concomitant medications.

**Correct Answer: C. Isoniazid is primarily used in the treatment of tuberculosis and is not as effective against M. leprae as rifampicin.